King Pharmaceuticals, Inc. (NYSE: KG)

Sector: Medical

Current Price : $14.24

52 Week Low
$7.4252 Week High
$14.25

Press Releases
Klondike Gold Corp.: Richard Hughes Resigns as Director
Klondike Gold Retains Investment Relations Professional
Klondike Gold Corp. Closes Oversubscribed Private Placement
Klondike Gold Corp.: Portuguese Exploration Licences Granted
Klondike Gold's Application Accepted on Three New Portuguese Exploration Licences
CORRECTION FROM SOURCE-Klondike Gold Corp.: 2012 South East BC Gold Exploration
Klondike Gold Corp.: 2012 South East BC Gold Exploration
Klondike Gold Corp.: Lone Star 2012 Exploration Summary
Klondike Gold Corp.: Private Placement Amendment
Klondike Gold Corp.: Private Placement
Klondike Gold Corp.: Hughes Range 2012 Exploration Results
Klondike Gold Corp. License Application Accepted for Historic Portuguese Gold Mine
Klondike Gold Corp. Consolidates 309 km2 Panda Basin Irishman Property
Klondike Gold Samples 179 g/t Gold with 78 g/t Silver and 98.8 g/t Gold with 20.7 g/t Silver on the Lone Star Property, Yukon Territory
Klondike Gold Completes Financing
Klondike Gold Samples 47.4 g/t Gold and 894 g/t Silver Along the Violet Vein Trend
Klondike Gold Corp.: Indian River Placer Gold Mine Concludes Construction on Schedule and Prepares for Gold Production
Klondike Gold Corp. Announces Private Placement
Klondike Gold Corp.: Joint Venture Sets Stage for Placer Gold Production on Indian River Project
Klondike Gold Options SE British Columbia Property
Klondike Gold Corp. Advances Consolidation of Yukon Mining Interests
Klondike Gold Reports Initial Results from Its Fall 2011 Yukon Work Program
Klondike Gold Closes Private Placement
Investment Industry Regulatory Organization of Canada - Trade Resumption - Klondike Gold Corp. - KG
Investment Industry Regulatory Organization of Canada - Trading Halt - Klondike Gold Corp - KG
Klondike Reactivated
Decade in Review: Pharmaceutical Sector Leads Health Care M&A
King Pharmaceuticals, Inc. Announces Final Results of Its Offer to Purchase Convertible Notes
ACUROX(R) Tablets New Drug Application Accepted for Filing With a Priority Review Classification
King Pharmaceuticals, Inc. Announces Intent to Voluntarily Delist From the New York Stock Exchange
Pfizer Announces HSR Clearance for the Acquisition of King Pharmaceuticals
REMOXY? New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011
Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.
Standard & Poor's Announces Changes to U.S. Indices
Acura Pharmaceuticals Reports 3rd Qtr 2010 Financial Results and Product Development Update
Fitch: Pfizer's Acquisition of King Not Expected to Affect Ratings
UPI NewsTrack Business

iStock Rating

King Pharmaceuticals, Inc. (NYSE: KG)

Sector: Medical

Company

Community

Analysis

Charts

Analyst

Ratios